• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL Back to Search Results
Catalog Number BXA087902E
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Death (1802); Ischemia (1942); Thrombosis (2100)
Event Date 08/26/2020
Event Type  Death  
Manufacturer Narrative
A review of the manufacturing records indicated the lot met all pre-release manufacturing specifications.Dicom series have been requested and provided.They are currently being evaluated.The device remains implanted.Therefore an engineering evaluation could not be performed.Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Event Description
On (b)(6) 2020, the patient underwent a branched endovascular aortic repair (bevar) to treat a thoraco-abdominal aneurysm type v with customized main aortic endoprosthesis (cook).Four gore® viabahn® vbx balloon expandable endoprostheses (viabahn vbx device) were implanted to extend the branches into the left renal artery, the right renal artery, the superior mesenteric artery (sma) and the celiac artery (ca).The viabahn vbx devices in sma and ca were extended with a begraft peripheral plus stent graft (bentley).All viabahn vbx devices were navigated to their intended locations and deployed without issues.At the end of the procedure all viabahn vbx devices were patent.The patient tolerated the procedure.On (b)(6) 2020, the patient was admitted to the hospital because of severe abdominal pain for three days.Reportedly the patient has discontinued the anticoagulation medication because of increasing nausea and vomiting.Blood test marker results for inflammation indicated sever inflammatory processes.An x-ray imaging indicated an ileus of the small intestine.A computed tomography showed that all implanted endoprosthesis were located as intended.It is stated that the patient gradually went into shock, so they decided to have emergency laparotomy.Reportedly there was a very bad smell and no pulse was present at the level of the mesenteric root.The small intestine was ischemic reaching from the suspensory ligament of treitz to the ileocecal valve.The laparotomy was terminated without further action.On (b)(6) 2020, the patient passed away because of advanced stage small intestine ischemia.
 
Manufacturer Narrative
H6-code 4112: dicom series have been provided for investigation.H6-code 213: the imaging evaluation states the following: three time points submitted for evaluation: pre-implantation cta dated on (b)(6) 2020, post-implantation cta dated on (b)(6) 2020 and post-implantation ct (non-contrast) dated on (b)(6) 2020.Sagittal reconstructed images from on (b)(6) 2020 time point appear to show stents extending into the celiac artery and sma.The celiac artery and sma appear to be patent on this time point.Last time point on (b)(6) 2020 is a non-contrast ct.Flow through the stents cannot be confirmed or unconfirmed without contrast.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN VBX BALLOON EXPANDABLE ENDOPROSTHESIS
Type of Device
ILIAC COVERED STENT, ARTERIAL
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key10770339
MDR Text Key214109164
Report Number2017233-2020-01396
Device Sequence Number1
Product Code PRL
Combination Product (y/n)Y
PMA/PMN Number
P160021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type study
Type of Report Initial,Followup
Report Date 11/12/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/02/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Expiration Date09/25/2022
Device Catalogue NumberBXA087902E
Was Device Available for Evaluation? No
Date Manufacturer Received11/09/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death; Hospitalization; Life Threatening; Disability;
Patient Age80 YR
Patient Weight100
-
-